Article
Author(s):
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA
3 Things You Should Know About Interventional Glaucoma Comanagement
NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis suggests potential benefits
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Annexon completes enrollment in phase 3 ARCHER II trial of vonaprument for geographic atrophy
Kiora Pharmaceuticals Secures US Patent for KIO-104